Back
Cellebrite DI 10K Form
Sell
21
CLBT
Cellebrite DI
Last Price:
17.72
Seasonality Move:
0.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLBT News And Ratings
See the #1 stock for the next 7 days that we like better than CLBT
CLBT Financial Statistics
Sales & Book Value
| Annual Sales: | $325.11M |
|---|---|
| Cash Flow: | $39.83M |
| Price / Cash Flow: | 35.78 |
| Annual Sales: | $1.39 |
| Price / Book: | 12.75 |
Profitability
| EPS (TTM): | -1.55000 |
|---|---|
| Net Income (TTM): | $-316.92M |
| Gross Margin: | $271.88M |
| Return on Equity: | -521.93% |
| Return on Assets: | -58.16% |
Cellebrite DI Earnings Forecast
Key Cellebrite DI Financial Ratios
- The Gross Profit Margin over the past 5 years for CLBT is 83.63%.
- The Selling, General & Administrative Expenses for CLBT have been equal to 47.45% of Gross Profit Margin.
- The Research & Development expenses have been 25.96% of Revenue.
- The Interest Expense is -0.17% of Operating Income.
- The Net Earning history of CLBT is -24.95% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Cellebrite DI Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | CLBT |
| Website: | cellebrite.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.84 |
| Quick Ratio: | 1.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 44.28 |
CLBT Technical Analysis vs Fundamental Analysis
Sell
21
Cellebrite DI (CLBT)
is a Sell
Is Cellebrite DI a Buy or a Sell?
-
Cellebrite DI stock is rated a Sell
The current Cellebrite DI [CLBT] share price is $17.70. The Score for CLBT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.